Supplementary S1 Legend a) Quantification of total cell number after primary sphere trituration at day 5 in vitro. OC derived sphere forming cells were treated with different concentrations/combinations of Wnt3a and R-Spondin1 as indicated. OC from n=12 (age p5) animals were pooled after initial trituration and re-distributed over 12 wells of a 24 well plate. Recombinant proteins were added at day 0. Triplicate samples were analyzed per conditions. b) Representative brightfield images of the spheres at day 5 treated with different concentrations/combinations of Wnt3a and R-Spondin1 as indicated. Scale bar 100µm c) Quantification of total cell number after primary sphere trituration at day 5 in vitro. OC derived sphere forming cells were treated with different concentrations of CHIR99021 as indicated. OC from n=7 (age p5) animals were pooled after initial trituration and re-distributed over 15 wells of a 24 well plate. CHIR99021 was added at day 0. Triplicate samples were analyzed per conditions. 0.1% DMSO was used as control.
Supplementary S2 Legend
Representative images of 5DIV spheres isolated from Lgr5 GFP animals (age p5), treated with different concentrations/combinations of Wnt3a and R-Spondin1 as indicated. Brightfield and GFP channels are shown. Scale bar 100µm. B) Representative example of GFP+ cells quantification by flow cytometry for the indicated treatment at 5DIV c) Quantification of GFP+ cells by flow cytometry after 5DIV in untreated samples, Wnt3a (20ng/ml)/R-Spondin1(250ng/ml) (W/R) treated or CHIR99021 treated (10µM) cells. Comparison with GFP+ percentage at day 0 is displayed. (n=3 independent experiment). d) Quantification of sphere size after W/R (Wnt3a (20ng/ml) /R-Spondin1(250ng/ml)) or CHIR99021(10µM) treatment at 5DIV.**** p<0.001 ANOVA multiple comparison. e) Representative example of untreated or CHIR99021 treated spheres plated on Matrigel TM coated plates after 5DIV and immunostained for SOX2. Scale bar 50µm. f) Quantification of the integrated density (pixel positive area x mean intensity), corrected for sphere area is plotted. 50 spheres from 2 independent experiments were analyzed for CHIR treatment; 35 spheres from 2 independent experiments for neg control.
(*Unpaired t test)
Supplementary S3 Legend a) Organotypic culture from Gem-AG FUCCI OC at day 0 and schematic of the reporter. Fluorescence microscopy shows lack of green fluorescence at the moment of isolation. Scale bar 50µm. b) Organotypic culture from Cdt1-KO2 FUCCI OC at day 0 and schematic of the reporter. Scale bar 50µm. c) Representative example of organ cultures, 5DIV, immunostained for Myo7a (yellow), Sox2 (green). Cdt1-KO2 (red) and DAPI (blu). Merged and single images are shown (middle cochlear turn). White boxed area is shown in right panels. Cdt1-Ko2**: oversaturated image to illustrate lack of nuclear fluorescence. Scale bar 100µm. d) Quantification of Cdt1-KO2-/Sox2+ cells in Organotypic culture. OC from 3 animals (age p5) were imaged by confocal microscopy. 10 different fields were imaged from basal to apex per OC and a total number of ca. 2000 Sox 2 cells was counted. Average +/-SEM is shown in the bar graph.
Supplementary S4 Legend
a) Schematic of the imaging strategy. b) Cumulative number of MyoVIIa+/Edu+ hair cells along the organ of Corti (as in schematic a) from 3 different animals (age p3). c) Representative image of organotypic OC cultures from wt animals (age p5), treated for 5 days with 10µM CHIR99021. Cells are immunostained for sox2 (green), Ki67 (red) and DAPI (blu). Scale bar 100µm. Apex, middle and basal turns are shown. White boxed areas are enlarged: Merged images and single channels are displayed. Yellow arrows point as some selected double positive cells.
